Patent Assignment
Reel/Frame 067487/0445
Assignment of Assignor's Interest
Recorded: 2024-05-21
Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2024-05-13
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties
(11)
Bupropion and Dextromethorphan for Reduction of Suicide Risk in Depression Patients
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
Treatment of Depression
Application:
18/418,010 →
Publication:
US US20240165104A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Method of Maintaining Remission of Depressive Symptoms
Application:
18/435,115 →
Publication:
US US20240238276A1
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Application:
63/557,860 →
Bupropion and Dextromethorphan for Treating Nicotine Addiction
Application:
18/589,348 →
Publication:
US US20240252451A1
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
Bupropion and Dextromethorphan for Treating Nicotine Addiction
Application:
18/590,435 →
Publication:
US US20240197656A1
Combination of Dextromethorphan and Bupropion for Treating Depression
Application:
18/601,603 →
Publication:
US US20240269130A1
Bupropion as a Modulator of Drug Activity